Showing 1 - 10 of 50
The small sample size of contingent valuation (CV) surveys conducted in patients may have limited the use of the single-bounded (SB) dichotomous choice format which is recommended in environmental economics. In this paper, we explore two ways to increase the statistical efficiency of the SB...
Persistent link: https://www.econbiz.de/10009353550
How much of the failures to achieve Pareto efficient outcome observed in a simple 2 x 2 dominance solvable game can be attributed to strategic uncertainty and how much is actually due to individual bounded rationality? We address this question by conducting a set of experiments involving two...
Persistent link: https://www.econbiz.de/10014158286
Tests are crucial to know about the number of people who have fallen ill with COVID-19 and to understand in real-time whether the dynamics of the pandemic is accelerating or decelerating. But tests are a scarce resource in many countries. The key but still open question is thus how to allocate...
Persistent link: https://www.econbiz.de/10014099687
Persistent link: https://www.econbiz.de/10015154277
Objectives: This note provides an assessment of COVID-19 acceleration among groups with different vaccine status in France.Methods: We assess viral acceleration using a novel indicator introduced in Baunez et al. (2021). The acceleration index relates the percentage change of tests that have...
Persistent link: https://www.econbiz.de/10013324430
We study time preferences by means of a longitudinal lab experiment involving both monetary and non-monetary rewards (leisure). Our novel design allows to measure whether participants prefer to anticipate or delay gratification, without imposing any structural assumption on the instantaneous...
Persistent link: https://www.econbiz.de/10013216566
Persistent link: https://www.econbiz.de/10008648177
Persistent link: https://www.econbiz.de/10010423243
Persistent link: https://www.econbiz.de/10011706181
We argue that reluctance to invest in drug treatments to fight the AIDS epidemics in developing countries is largely motivated by severe losses occurring from the future albeit uncertain appearance of a curative vaccine. We design a set of securities generating full insurance coverage against...
Persistent link: https://www.econbiz.de/10013149797